Buffalo-based POP Biotechnologies develops nanotechnology platforms for vaccines, immunotherapies and light-activated cancer drug delivery. Its patented SNAP technology forms nanoliposome vaccines by binding His-tagged antigens to CoPoP liposomes, and has supported EuCorVac-19, a COVID-19 vaccine that met primary endpoints in a Phase 3 study. The company also produces CoPoP under GMP at a 2.5-million-dose scale and is advancing PhotoDOX, which uses red light to trigger localized doxorubicin release in solid tumors.
Good Manufacturing Practice (GMP)
compliance_program
GLP Toxicology
compliance_program
Financial Conflict of Interest Policy
compliance_program
TechnoVax IncFounded in 2004, privately held TechnoVax is a New York metro-area biotechnology company developing viral vaccines through a cell-based virus-like particle platform. Its near-clinical-stage work centers on vaccine candidates for influenza and RSV, including an inhaled powder approach developed with a pulmonary drug-delivery partner. The company also provides biological products and collaborative research services for vaccine, diagnostic, and research applications.ELMSFORD, NY
NovavaxHeadquartered in Gaithersburg, Maryland, Novavax is a biotech company that develops vaccines and vaccine technologies, pairing protein-based nanoparticles with its proprietary Matrix-M® adjuvant. Its platform underpins marketed vaccines for COVID-19 and malaria, while the company continues in-house R&D and works with pharmaceutical, research and government partners to advance additional medicines. Novavax also conducts R&D and Matrix-M manufacturing in Uppsala, Sweden.GAITHERSBURG, MD
Nanobrid Innovations Private LimitedNanobrid Innovations Private Limited is an Indian nanotechnology company developing formulation solutions for drug delivery. Its proprietary Nanobrid® platform is intended to help deliver difficult-to-formulate active ingredients more effectively and conveniently for patients.RAJASTHAN, IN
Aquavit Pharmaceuticals, IncFounded in New York City in 2010, Aquavit Pharmaceuticals is a biotechnology company known for developing personalized healthcare through modern drug-delivery systems. Its patented micro-channel platform is designed to deliver therapeutic agents directly into the skin, supporting more targeted treatment while minimizing systemic toxicity. Aquavit has commercialized AQUAGOLD® and maintains an intellectual-property portfolio of more than 30 patents and 25 trademarks.NEW YORK, NY